by Skyler Crabill | Aug 5, 2022
The CNS drug development drum beat is getting louder By Brian Buntz | August 1, 2022 [image courtesy of Pixabay] The late 1980s and the 1990s were something of a gold rush for pharmaceutical companies focused on CNS drug development — especially those developing...
by Irene Morgenstern | Jun 29, 2022
PsychoGenics Strengthens Executive Team to Boost CNS Drug Discovery and CRO Capabilities Biopharmaceutical Industry Veterans David Bleakman and Thomas Oakley Each Bring Three Decades of Experience to the Company Paramus, N.J., June 28, 2022 – PsychoGenics Inc....
Recent Comments